Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the control of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://safaxidt978613.targetblogs.com/39357288/semaglutide-a-potential-solution-for-obesity